Characterization of choline uptake in Trypanosoma brucei procyclic and bloodstream forms

Molecular and Biochemical Parasitology

Volumn 190, Issue 1, 2013, Pages 16-22

  Macedo, Juan P ^a   Schmidt, Remo S ^a   Mäser, Pascal ^b   Rentsch, Doris ^a   Vial, Henri J ^c   Sigel, Erwin ^a   Bütikofer, Peter ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Choline; Kinetics; Phosphatidylcholine; Transport; Trypanosoma

Indexed keywords

ANTIMALARIAL AGENT; CHOLINE; CHOLINE DERIVATIVE; HEMICHOLINIUM 3; PHOSPHATIDYLCHOLINE; POTASSIUM ION; SODIUM ION;

ARTICLE; CELL MEMBRANE; CELL VIABILITY; CHOLINE UPTAKE; CONTROLLED STUDY; DRUG SENSITIVITY; EUKARYOTIC CELL; GENE SILENCING; GROWTH INHIBITION; IC 50; LIPOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIOACTIVITY; RNA INTERFERENCE; SEQUENCE HOMOLOGY; STABLE TRANSFECTION; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EUKARYOTA; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 84879474713     PISSN: 01666851     EISSN: 18729428     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2013.05.007     Document Type: Article

References (33)

1. Smith TK, Bütikofer P. Lipid metabolism in Trypanosoma brucei. Molecular andBiochemical Parasitology 2010;172:66-79.
2. Patnaik PK, Field MC, Menon AK, Cross GA, Yee MC, Bütikofer P. Molecularspecies analysis of phospholipids from Trypanosoma brucei bloodstream andprocyclic forms. Molecular and Biochemical Parasitology 1993;58:97-105. (Pubitemid 223039627)
3. Bowes AE, Samad AH, Jiang P, Weaver B, Mellors A. The acquisition of lysophos-phatidylcholine by African trypanosomes. Journal of Biological Chemistry1993;268:13885-92.
4. Mellors A, Samad A. The acquisition of lipids by African trypanosomes. Para-sitology Today (Regul Ed) 1989;5:239-44. (Pubitemid 19209407)
5. Gibellini F, Hunter WN, Smith TK. Biochemical characterization of the initialsteps of the Kennedy pathway in Trypanosoma brucei: the ethanolamine andcholine kinases. Biochemical Journal 2008;415:135-44.
6. Signorell A, Rauch M, Jelk J, Ferguson MAJ, Bütikofer P. Phos-phatidylethanolamine in Trypanosoma brucei is organized in two separatepools and is synthesized exclusively by the Kennedy pathway. Journal ofBiological Chemistry 2008;283:23636-44.
7. Ibrahim HMS, Al-Salabi MI, El Sabbagh N, Quashie NB, Alkhaldi AAM, Escale R,et al. Symmetrical choline-derived dications display strong anti-kinetoplastidactivity. Journal of Antimicrobial Chemotherapy 2011;66:111-25.
8. Richmond GS, Gibellini F, Young SA, Major L, Denton H, Lilley A, et al. Lipidomicanalysis of bloodstream and procyclic form Trypanosoma brucei. Parasitology2010;137:1357-92.
9. Guyenet P, Lefresne P, Rossier J, Beaujouan JC, Glowinski J. Inhibition byhemicholinium-3 of (14C)acetylcholine synthesis and (3H)choline high-affinityuptake in rat striatal synaptosomes. Molecular Pharmacology 1973;9:630-9.
10. Michel V, Yuan Z, Ramsubir S, Bakovic M. Choline transport for phospholipidsynthesis. Experimental Biology and Medicine (Maywood) 2006;231:490-504.
11. Okuda T, Haga T. Functional characterization of the human high-affinity cholinetransporter. FEBS Letters 2000;484:92-7.
12. Apparsundaram S, Ferguson SM, George AL, Blakely RD. Molecular cloning of ahuman, hemicholinium-3-sensitive choline transporter. Biochemical and Bio-physical Research Communications 2000;276:862-7.
13. Zufferey R, Mamoun CB. Choline transport in Leishmania major promastig-otes and its inhibition by choline and phosphocholine analogs. Molecular andBiochemical Parasitology 2002;125:127-34. (Pubitemid 35449252)
14. Biagini GA, Pasini EM, Hughes R, de Koning HP, Vial HJ, O'Neill PM, et al. Char-acterization of the choline carrier of Plasmodium falciparum: a route for theselective delivery of novel antimalarial drugs. Blood 2004;104:3372-7. (Pubitemid 39507161)
15. Peyrottes S, Caldarelli S, Wein S, Prigaud C, Pellet A, Vial H. Choline analoguesin malaria chemotherapy. Current Pharmaceutical Design 2012;18:3454-66.
16. Wein S, Maynadier M, Bordat Y, Perez J, Maheshwari S, Bette-Bobillo P, et al.Transport and pharmacodynamics of albitiazolium, an antimalarial drug can-didate. British Journal of Pharmacology 2012;166:2263-76.
17. Roggero R, Zufferey R, Minca M, Richier E, Calas M, Vial H, et al. Unraveling themode of action of the antimalarial choline analog G25 in Plasmodium falcip-arum and Saccharomyces cerevisiae. Antimicrobial Agents and Chemotherapy2004;48:2816-24. (Pubitemid 38989141)
18. Calas M, Ancelin ML, Cordina G, Portefaix P, Piquet G, Vidal-Sailhan V, et al.Antimalarial activity of compounds interfering with Plasmodium falciparumphospholipid metabolism: comparison between mono- and bisquaternaryammonium salts. Journal of Medicinal Chemistry 2000;43:505-16. (Pubitemid 30102090)
19. Wirtz E, Leal S, Ochatt C, Cross GA. A tightly regulated inducible expres-sion system for conditional gene knock-outs and dominant-negative geneticsin Trypanosoma brucei. Molecular and Biochemical Parasitology 1999;99:89-101. (Pubitemid 29127189)
20. Bütikofer P, Ruepp S, Boschung M, Roditi I. GPEET' procyclin is the major sur-face protein of procyclic culture forms of Trypanosoma brucei brucei strain 427.Biochemical Journal 1997;326(Pt 2):415-23. (Pubitemid 27417218)
21. Räz B, Iten M, Grether-Bühler Y, Kaminsky R, Brun R. The Alamar Blue assay todetermine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b.gambiense) in vitro. Acta Tropica 1997;68:139-47. (Pubitemid 27438330)
22. Käll L, Krogh A, Sonnhammer ELL. A combined transmembrane topol-ogy and signal peptide prediction method. Journal of Molecular Biology2004;338:1027- 36. (Pubitemid 38542831)
23. Needleman SB, Wunsch CD. A general method applicable to the search for simi-larities in the amino acid sequence of two proteins. Journal of Molecular Biology1970;48:443-53.
24. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H,et al. Clustal W and Clustal X version 2. Bioinformatics 2007;23:2947-8.
25. Eddy SR. Profile hidden Markov models. Bioinformatics 1998;14:755-63. (Pubitemid 28552108)
26. Söding J. Protein homology detection by HMM-HMM comparison. Bioinfor-matics 2005;21:951-60. (Pubitemid 40467915)
27. Bochud-Allemann N, Schneider A. Mitochondrial substrate level phosphoryla-tion is essential for growth of procyclic Trypanosoma brucei. Journal of BiologicalChemistry 2002;277:32849-54. (Pubitemid 34984796)
28. Dohmen RJ, Strasser AW, Höner CB, Hollenberg CP. An efficient transforma-tion procedure enabling long-term storage of competent cells of various yeastgenera. Yeast 1991;7:691-2.
29. Sigel E. Use of Xenopus oocytes for the functional expression of plasma mem-brane proteins. Journal of Membrane Biology 1990;117:201-21. (Pubitemid 20279780)
30. Das I, de Belleroche J, Moore CJ, Rose FC. Determination of free choline inplasma and erythrocyte samples and choline derived from membrane phos-phatidylcholine by a chemiluminescence method. Analytical Biochemistry1986;152:178-82. (Pubitemid 16140451)
31. Raffelt K, Moka D, Süllentrop F, Dietlein M, Hahn J, Schicha H. Systemic alter-ations in phospholipid concentrations of blood plasma in patients with thyroidcarcinoma: an in-vitro (31)P high-resolution NMR study. NMR in Biomedicine2000;13:8-13. (Pubitemid 30136997)
32. Takatera A, Takeuchi A, Saiki K, Morisawa T, Yokoyama N, Matsuo M. Quan-tification of lysophosphatidylcholines and phosphatidylcholines using liquidchromatography-tandem mass spectrometry in neonatal serum. Journal ofChromatography B: Analytical Technologies in the Biomedical and Life Sciences2006;838:31-6. (Pubitemid 43832208)
33. Vial HJ, Wein S, Farenc C, Kocken C, Nicolas O, Ancelin ML, et al. Prodrugs ofbisthiazolium salts are orally potent antimalarials. Proceedings of the NationalAcademy of Sciences United States 2004;101:15458-63. (Pubitemid 39441563)